CRISPR Therapeutics AG (LON:0VRQ)
London · Delayed Price · Currency is GBP · Price in USD 72.15
-1.73 (-2.34%)
At close: Oct 10, 2025
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of 4.66 billion as of October 13, 2025. Its market cap has increased by 51.86% in one year.
Market Cap
4.66B
Enterprise Value
3.53B
Revenue
27.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
72.15
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from 451.35M to 4.66B, an increase of 932.41%. That is a compound annual growth rate of 29.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 4.66B | 73.65% |
| Dec 31, 2024 | 2.68B | -31.26% |
| Dec 29, 2023 | 3.90B | 47.79% |
| Dec 30, 2022 | 2.64B | -38.32% |
| Dec 31, 2021 | 4.28B | -45.95% |
| Dec 31, 2020 | 7.92B | 189.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 198.21B |
| HSBC Holdings | 171.17B |
| Shell | 156.47B |
| Unilever | 111.66B |
| Rolls-Royce Holdings | 95.87B |
| Rio Tinto Group | 85.09B |
| British American Tobacco p.l.c. | 83.51B |
| GSK plc | 65.38B |